Kre-Alkalyn EFX

General: Product/Version Code

AAC8263-192

Brand IP Statement(s) re: (c), (TM), (SM)

Elite athletes using 7.5g of Kre-Alkalyn(R). Individual results may vary. Referenced: (1) Stoychev K., Terziiski N. (2006). “Comparison of Kre-Alkalyn to Creatine...performance, & safety”.

Brand IP Statement(s) re: (c), (TM), (SM)

pH-Correct(R) Creatine!*

General Statements: All Other Content

PRE-WORKOUT & POST-WORKOUT

Brand IP Statement(s) re: (c), (TM), (SM)

THE KRE-ALKALYN(R) EFX DIFFERENCE IT’S BUFFERED. IT’S STABLE. IT WORKS!*

General Statements: All Other Content

FROM THE LAB TO THE GYM!

Brand IP Statement(s) re: (c), (TM), (SM)

Twenty-four elite athletes from the Bulgarian National Weightlifting Team were selected to participate in a double-blind clinical study(1) comparing Kre-Alkalyn(R) to standard creatine monohydrate.

Brand IP Statement(s) re: (c), (TM), (SM)

After 60 days, the Kre-Alkalyn(R) group (using 7.5g per day) experienced an overall average strength increase of 28.25% above those in the unbuffered creatine monohydrate group!

Brand IP Statement(s) re: (c), (TM), (SM)

U.S. Patent#6,399,661 New Zealand Patent #519305 Australian Patent #2003203344

General Statements: All Other Content

Buffered. Stable. Patented!*

Seals/Symbols

The ORIGINAL Kre-Alkalyn(R) from the ORIGINAL Company

FDA Statement of Identity

DIETARY SUPPLEMENT

Suggested/Recommended/Usage/Directions

SUGGESTED USE: As a dietary supplement, take 1 capsule 30 minutes pre-workout and 1 post-workout.

Suggested/Recommended/Usage/Directions

DAILY DOSING GUIDE FOR BEST RESULTS: UP TO 175 lbs. 1 Cap Before & After Workout / 175 lbs. & ABOVE 2 Caps Before & After Workout

Brand IP Statement(s) re: (c), (TM), (SM)

EU Patent# 1000135313

Seals/Symbols

Kre-Alkalyn(R)

Brand IP Statement(s) re: (c), (TM), (SM)

Kre-Alkalyn(R) is a patented product (US # 6,399,661) and registered trademark of All American Pharmaceutical.

General Statements: All Other Content

Made in the USA. In God We Trust.

Brand IP Statement(s) re: (c), (TM), (SM)

(C)2012 All American(R) EFX

Brand IP Statement(s) re: (c), (TM), (SM)

Kre-Alkalyn(R) EFX represent a major breakthrough in performance supplementation thanks to its multi-patented, 'pH-Correct(R)' creatine stabilization technology. Our scientist discovered that “buffering” to pH-12 produced a stable creatine molecule. Kre-Alkalyn(R) EFX is the only creatine monohydrate product with a pH of 12 because its molecules are synthesized with ‘buffering’ agents using a patented manufacturing process.

General Statements: All Other Content

{image} CREATINE MONOHYDRATE Kre-Alkalyn

Brand IP Statement(s) re: (c), (TM), (SM)

Jeff Golini, (Kre-Alkalyn(R) Inventor and Patent Holder)

General Statements: All Other Content

Tested For Purity And Banned Substances!*

Seals/Symbols

INFORMED-CHOICE {check}.ORG Trusted by sport

Storage

STORAGE: Keep lid tightly closed in a cool, dry place away from children.

Precautions re: Children

STORAGE: Keep lid tightly closed in a cool, dry place away from children.

FDA Disclaimer Statement

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

General Statements: All Other Content

20% MORE FREE!